[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-336197-105":59,"doc-detail-336197-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","proteomics-and-its-applications-in-cancers-20-editorial","Proteomics and Its Applications in Cancers 2.0 - Editorial","","The editorial introduces the Special Issue “Proteomics and Its Applications in Cancers 2.0,” created to attract additional submissions on cancer proteomics. It summarizes the aim of cancer research by linking malignant cell reorganization to protein composition changes and explains how proteomics supports biomarker discovery through protein abundance, pathway participation, interactions, and post-translational modifications. The issue emphasizes immune-response related epitomics and proteoform profiling, citing studies that identify specific epitope variants in lung cancer and discuss cryptoproteins and validation needs for clinical biomarker use.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/proteomics-and-its-applications-in-cancers-20-editorial/336197/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/proteomics-and-its-applications-in-cancers-20-editorial/336197.png","ImageObject",300,407,{"name":92,"@type":93},"Emma Wilson","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the purpose of the Special Issue “Proteomics and Its Applications in Cancers 2.0”?","Question",{"text":112,"@type":113},"It aims to attract more publications involving cancer proteomics, building on the success of the previous Special Issue and presenting one review plus eight research papers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does proteomics help in cancer biomarker discovery?",{"text":117,"@type":113},"By detailing changes in the proteome, proteomics can reveal protein quantities, participation in metabolic pathways, interactions, post-translational modifications, and protein synthesis/degradation that support biomarker search.",{"name":119,"@type":110,"acceptedAnswer":120},"What special topic related to cancer biomarkers is highlighted in the issue?",{"text":121,"@type":113},"Immune response and epitomics, including protein epitome profiling and monitoring variation at the level of proteoforms and epitopes.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},336197,1790525442,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":81,"preview_urls":144},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Editorial  \nProteomics and Its Applications in Cancers 2.0 Stanislav Naryzhny   \nCitation: Naryzhny, S. Proteomicsand Its Applications in Cancers 2.0 . Int. J. Mol. Sci. 2024, 25, 4447 . [https://doi.org/10.3390/ijms25084447](https://doi.org/10.3390/ijms25084447)  \nReceived: 29 February 2024  \nRevised: 10 April 2024  \nAccepted: 15 April 2024  \nPublished: 18 April 2024  \nCopyright: © 2024 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nPetersburg Nuclear Physics Institute Named by B.P. Konstantinov of National Research Centre “Kurchatov Institute”, 188300 Gatchina, Russia; [snaryzhny@mail.ru](snaryzhny@mail.ru)  \nConsidering the success of our previous Special Issue (SI)“Proteomics and Its Applications in Cancers”, we aimed to attract more publications where cancer proteomics is involved. Altogether, the SI “Proteomics and Its Applications in Cancers 2.0” presents one review and eight research papers.  \nCancer is a systemic malignant degeneration of cells that can affect all human organs. Cancer is among the leading causes of death worldwide ([https://www.who.int/news](https://www.who.int/news)room/fact-sheets/detail/cancer) (accessed on 11 April 2024) [1] . The main characteristic of cancer is the reorganization of the cell, causing its uncontrolled proliferation. Just one abnormal cell can grow into a tumor, which can penetrate into surrounding tissues and migrate to other organs, i.e., metastasize [2,3] . Since these processes are accompanied by changes in the protein composition (proteome) of the tissue and organism, proteomicscan provide detailed information with regard to this. For example, it may reveal key information that can facilitate the search for clinically applicable biomarkers for therapeutic purposes [4] . Proteomics can provide answers to general and specific questions—about the quantity and abundance of proteins, their participation in metabolic pathways, interactions, post-translational modifications (PTMs), as well as synthesis and degradation. Together with other large-scale omics-based studies (genomics, metabolomics, etc.), proteomics provides extensive data which can explain the molecular mechanisms of cancer [5] .  \nThe majority of the papers in this SI deals with the study of cancer biomarkers [6–8] . This area is an everlasting “hot topic” in cancer studies. It is not surprising that cancerand biomarker-specific journals publish copious manuscripts devoted to this area. In this regard, the Special Issue of this IJMS journal fits the situation very well. The other papers of the SI, not directly involved in cancer biomarkers, offer insight into general aspects of the cellular proteome organization and protein–protein interactions [9–12] .  \nA specific aspect of cancer biomarkers that is highlighted in this SI that warrants special attention is the topic of immune response, in particular, the omics-based study of epitomics [13] . Epitomics, or protein epitome profiling, is a tool for understanding subprotein-level variation [14] . Recently, studies in the field of proteomics have begun to pay more attention not only to quantitative changes in protein levels, but also to the development of systematic approaches to monitor variation at the level of specific protein forms—proteoforms. These proteoforms can arise due to alternative splicing, PTMs, processing, and degradation [15,16] . Moreover, as a result, these proteoforms that have specific surface structures can expose different epitopes and carry out different functions. These epitopes can be detected using monoclonal antibodies. Accordingly, a robust and analytically validated PEP (protein epitome profiling) technology that detects the variability of epitopes has ","cbCaivmKeDQ9Yzxq","https://ap.wps.com/l/cbCaivmKeDQ9Yzxq","pdf",396734,"English","# Editorial overview\n## Goals of the special issue\n## Proteomics in cancer research\n## Biomarkers and immune response (epitomics)\n## Examples from selected studies\n## Validation and impact","[{\"question\":\"What is the purpose of the Special Issue “Proteomics and Its Applications in Cancers 2.0”?\",\"answer\":\"It aims to attract more publications involving cancer proteomics, building on the success of the previous Special Issue and presenting one review plus eight research papers.\"},{\"question\":\"How does proteomics help in cancer biomarker discovery?\",\"answer\":\"By detailing changes in the proteome, proteomics can reveal protein quantities, participation in metabolic pathways, interactions, post-translational modifications, and protein synthesis/degradation that support biomarker search.\"},{\"question\":\"What special topic related to cancer biomarkers is highlighted in the issue?\",\"answer\":\"Immune response and epitomics, including protein epitome profiling and monitoring variation at the level of proteoforms and epitopes.\"}]","Proteomics and Its Applications in Cancers 2.0 - Editorial | PDF",1790014078,[145,149,153],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3bc27b1260fe3d5000f29fed8adf9cd8.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2a6eadafc527b1cf18f6a95ed8d08922.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/be2029d47641b3b070f8c090f75b3353.webp",981,1387]